Skip to main content
Erschienen in: Journal of Cancer Survivorship 3/2020

01.06.2020

Do esophageal cancer survivors work after esophagectomy and do health problems impact their work? A cross-sectional study

verfasst von: B. F. Kingma, P. Rauwerdink, H. J. F. Brenkman, J. P. Ruurda, R. van Hillegersberg

Erschienen in: Journal of Cancer Survivorship | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to evaluate the occupational status and work impediments due to health problems in long-term esophageal cancer survivors.

Methods

The Short-Form Health and Labour Questionnaire (SF-HLQ) was sent to esophageal cancer survivors. Primary outcomes included the number of working esophageal cancer survivors and the patient-reported impact of health problems on work, as evaluated by the SF-HLQ. Patient and treatment characteristics were compared between survivors who worked and survivors who did not work at the time of follow-up after esophagectomy.

Results

The SF-HLQ was sent to 98 survivors and was completed by 86 of them. Of the 86 included survivors, 35 worked at the time of cancer diagnosis and 18 worked at a median follow-up of 48 months [range 23–87] after treatment. Survivors who worked at the time of follow-up were younger at the time of treatment when compared to survivors who had quit working after their cancer diagnosis (58.4 vs. 64.2 years, P = 0.006). Working survivors most commonly reported reduced work pace (44%), a self-imposed need to work in seclusion (33%), and concentration problems (28%) due to health problems at work. The majority of working survivors (93%) reported an efficiency score ≥ 8 on a scale from 1 (lowest efficiency) to 10 (highest efficiency).

Conclusions

Nearly half of the esophageal cancer survivors who worked at the time of diagnosis also worked at a median follow-up of 48 months after esophagectomy. Despite health problems impacting work, most esophageal cancer survivors reported high efficiency at work.

Implications for Cancer Survivors

Esophageal cancer survivors can often work with high efficiency, despite potential health problems.
Literatur
2.
Zurück zum Zitat Merry AH, Schouten LJ, Goldbohm RA, van den Brandt PA. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut. 2007;56(11):1503–11.CrossRefPubMedPubMedCentral Merry AH, Schouten LJ, Goldbohm RA, van den Brandt PA. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut. 2007;56(11):1503–11.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130(11):883–90.CrossRefPubMed Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130(11):883–90.CrossRefPubMed
4.
Zurück zum Zitat Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165(12):1424–33 doi: kwm051 [pii].CrossRefPubMed Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, et al. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol. 2007;165(12):1424–33 doi: kwm051 [pii].CrossRefPubMed
7.
Zurück zum Zitat Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383–96.CrossRefPubMed Lagergren J, Smyth E, Cunningham D, Lagergren P. Oesophageal cancer. Lancet. 2017;390(10110):2383–96.CrossRefPubMed
9.
Zurück zum Zitat Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen M, Wijnhoven BPL, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–8.CrossRefPubMed Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen M, Wijnhoven BPL, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–8.CrossRefPubMed
13.
Zurück zum Zitat Mellon S, Northouse LL, Weiss LK. A population-based study of the quality of life of cancer survivors and their family caregivers. Cancer Nurs. 2006;29(2):120–31 quiz 132-3.CrossRefPubMed Mellon S, Northouse LL, Weiss LK. A population-based study of the quality of life of cancer survivors and their family caregivers. Cancer Nurs. 2006;29(2):120–31 quiz 132-3.CrossRefPubMed
18.
Zurück zum Zitat van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF. Labor and health status in economic evaluation of health care. the health and labor questionnaire. Int J Technol Assess Health Care. 1996;12(3):405–15.CrossRefPubMed van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FF. Labor and health status in economic evaluation of health care. the health and labor questionnaire. Int J Technol Assess Health Care. 1996;12(3):405–15.CrossRefPubMed
20.
27.
Zurück zum Zitat De Boer AG, Genovesi PI, Sprangers MA, Van Sandick JW, Obertop H, Van Lanschot JJ. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg. 2000;87(12):1716–21.CrossRefPubMed De Boer AG, Genovesi PI, Sprangers MA, Van Sandick JW, Obertop H, Van Lanschot JJ. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg. 2000;87(12):1716–21.CrossRefPubMed
33.
Zurück zum Zitat Kennedy F, Haslam C, Munir F, Pryce J. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care (Engl). 2007;16(1):17–25.CrossRef Kennedy F, Haslam C, Munir F, Pryce J. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care (Engl). 2007;16(1):17–25.CrossRef
Metadaten
Titel
Do esophageal cancer survivors work after esophagectomy and do health problems impact their work? A cross-sectional study
verfasst von
B. F. Kingma
P. Rauwerdink
H. J. F. Brenkman
J. P. Ruurda
R. van Hillegersberg
Publikationsdatum
01.06.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 3/2020
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-019-00834-1

Weitere Artikel der Ausgabe 3/2020

Journal of Cancer Survivorship 3/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.